BVF PARTNERS L P/IL Insider Trading for August 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BVF PARTNERS L P/IL for August 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | P | 19.75 | 2,244 | 44,308 | 1,709,157 | 1.7 M to 1.7 M (+0.13 %) |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | P | 19.31 | 5,179 | 100,003 | 1,706,913 | 1.7 M to 1.7 M (+0.30 %) |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | P | 19.32 | 1,607 | 31,050 | 1,701,734 | 1.7 M to 1.7 M (+0.09 %) |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | P | 19.75 | 3,443 | 67,982 | 1,986,945 | 2 M to 2 M (+0.17 %) |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | P | 19.31 | 6,504 | 125,588 | 1,983,502 | 2 M to 2 M (+0.33 %) |
Aug 25 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | Director | Buy | P | 19.32 | 9,198 | 177,720 | 1,976,998 | 2 M to 2 M (+0.47 %) |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 180,686 | 0 | 0 | |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 1,000,955 | 0 | 0 | |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Option Exercise | C | 0.00 | 1,336,390 | 0 | 0 | |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Grant | A | 20.00 | 67,791 | 1,355,820 | 181,081 | 113.3 K to 181.1 K (+59.84 %) |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 113,290 | 0 | 113,290 | 0 to 113.3 K |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Grant | A | 20.00 | 389,709 | 7,794,180 | 1,017,307 | 627.6 K to 1 M (+62.10 %) |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 627,598 | 0 | 627,598 | 0 to 627.6 K |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Grant | A | 20.00 | 521,193 | 10,423,860 | 1,359,109 | 837.9 K to 1.4 M (+62.20 %) |
Aug 25 2020 | KYMR | Kymera Therapeutic ... | BVF PARTNERS L P/IL | Director | Buy | C | 0.00 | 837,916 | 0 | 837,916 | 0 to 837.9 K |
Aug 20 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 19.12 | 1,772 | 33,881 | 1,967,800 | 2 M to 2 M (+0.09 %) |
Aug 20 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 19.70 | 3,496 | 68,877 | 1,966,028 | 2 M to 2 M (+0.18 %) |
Aug 20 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 19.27 | 895 | 17,246 | 1,962,532 | 2 M to 2 M (+0.05 %) |
Aug 20 2020 | PRNB | Principia Biopharm ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 100.00 | 158 | 15,800 | 3,547 | |
Aug 20 2020 | PRNB | Principia Biopharm ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 100.00 | 905 | 90,500 | 20,390 | |
Aug 20 2020 | PRNB | Principia Biopharm ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 100.00 | 1,205 | 120,500 | 27,265 | |
Aug 14 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 18.69 | 21,922 | 409,810 | 1,961,637 | 1.9 M to 2 M (+1.13 %) |
Aug 14 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 17.80 | 1,050 | 18,693 | 1,939,715 | 1.9 M to 1.9 M (+0.05 %) |
Aug 14 2020 | XOMA | XOMA Corp | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 17.34 | 4,050 | 70,233 | 1,938,665 | 1.9 M to 1.9 M (+0.21 %) |